Live WebinarValue preservation and hygiene management of treatment units—Important not only in times of corona
27 May 2020, 03:00 AM EST (New York)
May 18, 2020 | Business
NEW YORK, U.S.: Dentistry faces an earnest struggle to adapt to what some have called the new reality. A series of investor updates from major dental companies shows us that digital tools are now more important than ever for education and in customer service environments. Some dental companies have taken extraordinary measures to sure up manufacturing and supply, and significant adverse financial impacts have been shouldered.
April 22, 2020 | Events
ZURICH, Switzerland: With more than 10,000 unique registrations, the online edition of the 2020 Nobel Biocare Global Symposium, staged by Envista, was not only an extraordinary educational event but also an example of how remote teams can quickly adapt to unprecedented circumstances.
March 24, 2020 | Events
ZURICH, Switzerland: After careful consideration and monitoring of the ongoing spread of the virus SARS-CoV-2, Nobel Biocare has decided to postpone its 2020 Global Symposium, which was originally scheduled for 16–18 April in Las Vegas in the US. The symposium is now scheduled for early 2021. The company will communicate the new date and location as soon as details are available.
February 19, 2020 | Advertorial
After the success of the Nobel Biocare Global Symposium a few months ago, the event’s scientific committee chairman, Dr. Peter Wöhrle, will be a speaker and moderator at the upcoming Global Symposium 2020 in Las Vegas in the U.S. One of a few doctors worldwide with formal specialty training in the interrelated areas of implant surgery, implant prosthodontics and dental implant technology, here he provides insight into what implant professionals can expect from this world-class event.
January 08, 2020 | Events
BREA, Calif., U.S.: Envista is proud to announce the 2020 Nobel Biocare Global Symposium, to be held in Las Vegas from April 16 to 18. Empowered by a combination of expert knowledge and innovative solutions that are elevating patient care, the event will be a unique opportunity for dental professionals to explore the future of dental implantology and digital dentistry.
BREA, Calif., U.S.: Envista Holdings has announced that it is no longer bound to parent company Danaher. A successful exchange offering that closed on Dec. 13 saw the former parent company offload its remaining interest in Envista, which is now both fully independent and one of the largest dental companies in the world.
LISBON, Portugal: This year, Nobel Biocare opened a new chapter for implant dentistry with the launch of new surfaces and the introduction of the new Nobel Biocare N1 implant system. Visitors to the 28th Annual Scientific Meeting of the European Association for Osseointegration (EAO 2019) will have the opportunity tomorrow to view these groundbreaking innovations and discover more about them during an engaging symposium and through interactive hands-on sessions.
NEW YORK, USA: Danaher Corp. has successfully spun off its dental businesses into the company Envista Holdings in a successful public share offering that closed on Sept. 20. With the dental companies Nobel Biocare, Ormco and KaVo Kerr now under its wing, Envista has a unified global portfolio that will allow it to compete with other dental giants Dentsply Sirona and Straumann.
The recent Nobel Biocare Global Symposium saw many of the world’s leading voices on implantology and digital dentistry gather in the Spanish capital of Madrid. At the event, Dental Tribune International spoke with Dr. Pascal Kunz, Vice President of Digital Solutions at Nobel Biocare, about DTX Studio suite and the benefits it provides for both dental clinicians and patients.